Browse > Article

Growth Inhibition of Human Uterine Leiomyoma Cells Using Haeohyul-tang  

Kim, Han-Kyun (College of Oriental Medicine, Daegu Haany University)
Zhao, Rong-Jie (College of Oriental Medicine, Daegu Haany University, College of Medicine, Yanbian University)
Jo, Mi-Jeong (College of Oriental Medicine, Daegu Haany University)
Choi, Sun-Mi (Korea Institute of Oriental Medicine)
Park, Sook-Jahr (College of Oriental Medicine, Daegu Haany University, Development Team for The New Drug of Oriental Medicine (BK21 Program) Daegu Haany University)
Kim, Mi-Ryeo (College of Oriental Medicine, Daegu Haany University, Development Team for The New Drug of Oriental Medicine (BK21 Program) Daegu Haany University)
Kwon, Young-Kyu (College of Oriental Medicine, Daegu Haany University, Development Team for The New Drug of Oriental Medicine (BK21 Program) Daegu Haany University)
Kim, Sang-Chan (College of Oriental Medicine, Daegu Haany University, Development Team for The New Drug of Oriental Medicine (BK21 Program) Daegu Haany University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.21, no.1, 2007 , pp. 158-164 More about this Journal
Abstract
Uterine leiomyoma is the most common tumor in the female genital tract. Although the tumor is benign, it is a matter of paramount importance since it often causes profuse menstrual bleeding, pressure symptoms and infertility. Nevertheless, the etiology and pathophysiology of this abnormality remain poorly understood. The traditional definitive treatment for uterine leiomyomas is hysterectomy and, even today, symptomatic leiomyomas are the leading cause of hysterectomy in Korea. Clearly, the development of a safe, effective, and nonsurgical method of treatment for leiomyoma would be of great benefit to many women. This study demonstrated growth inhibition of uterine leiomyoma cells using Haeohyultang (HT). When human leiomyoma cells were treated with Haeohyultang, cells showed dose-dependent growth inhibitory effect. Cell growth was inhibited by over 40% as determined by both cell counts and MTS assay. Reduction of cellular viability as a consequence of exposure to Haeohyultang resulted from induction of apoptosis, as assessed by DNA fragmentation, PARP cleavage, caspase 9 and caspase 3 assay. Flow cytometry analysis with uterine leiomyoma cells demonstrated sub G1 cell cycle arrest after treatment with drug Haeohyultang. But, the expression levels of p27 and p21 were not changed in Haeohyultang treated cells compared with control. However, the expression levels of clAP1 were reduced by Haeohyultang compared with control. This reduction of clAP1 data means activation of the caspase family, and then induction of PARP cleavage and apoptosis. These results suggest that Haeohyultang may be potential therapeutic approach in the clinical management of uterine leiomyoma.
Keywords
Uterine leiomyoma; Haeohyultang; Apoptosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 신영우, 변영진, 나영호, 김창학, 권순욱. 복식 전자궁 적출술에 관한 임상 통계적 고찰. 대한산부회지 28:90, 1985
2 梁秀烈, 李京燮, 宋炳基. 子宮筋腫의 治驗1例. 大韓韓醫學會誌 11(1):33-38, 1990
3 이종학. 자궁근종에 대한 임상적 및 병리학적 연구. 대한산부인과학회지 30:213-222, 1987
4 송계승. 자궁근종의 임상통계학적 관찰. 대한산부인과학회지 30:981-988, 1987
5 Lipshultz, A. Expeimental fibroids and the antifibromatogenic action of steroid hormones. JAMA 120:173, 1984
6 金鍾桓. 子宮筋腫의 治療法에 關한 韓醫學的 考察. 大韓韓方婦人科學會誌 11(1):209-227, 1998
7 申鎭湜. 比較醫學的 側面에서 본 癥瘕의 疾病에 關한 文獻的 考察. 東醫病理學會誌. 1:67-70, 1984
8 白承嬉, 李京燮, 宋炳基. 七製香附丸이 子宮細胞株이 成長과 排卵 및 着床前胚發生에 미치는 影響. 大韓韓方婦人科學會誌 13(1):186-218, 2000
9 Brandon, D.D., Erickson, T.E., Keenan, E.J., Strawn, E.Y., Novy, M.J., Burry, K.A., Warner, C., Clinton, G.M. Estrogen receptor gene expression in human uterine leiomyomata. J. Clinic. Endocrinol. Metab. 80:1876-1881, 1995   DOI   ScienceOn
10 Murphy, A.A., Morales, A.J., Kettel, L.M., Yen, S.S. Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect. Fertil. Steril 64(1):187-190, 1995
11 Strawn, Jr E.Y., Novy, M.J., Burry, K.A., Bethea, C.L. Insulin-like growth factor I promotes leiomyoma cell growth in vitro. Am. J. Obstet. Gynecol. 172:1837-1844, 1995   DOI   ScienceOn
12 孫思邈. 備急千金要方. 北京, 人民衛生出版社. pp 59-62, 66, 211-215, 1982
13 전국한의과대학 본초학교수 공편저. 본초학. 서울, 영림사. pp 242-243, 423-424, 430-431, 1991
14 宋炳基. 邪客子門의 證治體系에 關한 考察. 서울, 醫林. pp 150, 1982
15 Buttram, V.C., Reiter, R.C. Uterine leiomyomata : Etiology, symptomatology, and management. Fertil. Steril. 36: 433-445, 1981   DOI
16 Matuo, H., Maruo, T., Samoto, T. Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone. J. Clinic. Endocrinol. Metab. 82:293-299, 1997   DOI   ScienceOn
17 華陀. 中藏經. 서울, 成輔社. pp 4, 13, 1978
18 許浚. 東醫寶鑑. 서울, 南山堂. pp 487, 490, 491, 1975
19 李京燮, 宋炳基. 癥瘕 狀態에 關한 文獻的 考察. 서울, 東洋醫學硏究室. pp 46-52, 1980
20 梁秀烈, 李京燮, 宋炳基. 癥瘕의 東西醫學的 考察. 大韓韓醫學會誌 7(1):84-88, 1986
21 金眞喜, 白承嬉. 桂枝茯苓丸이 子宮筋腫細胞의 成長억제와 MAP Kinase 活性에 미치는 影響. 大韓韓方婦人科學會誌 14(2):85-101, 2001
22 Lee, B.S., Nowak, R.A. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta3(TGF beta 3) and altered responses to the atiproliferative effects of TGF beta. J. Clinic. Endocrinol. Metab. 86:913-920, 2001   DOI   ScienceOn
23 Arici, A., Sozen, I. Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil. Steril. 73:1006-1011, 2000   DOI   ScienceOn
24 Klagsbrun, M., Dluz, S. Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen. J. Biol. Chem. 268: 18330-18334, 1993
25 梁秀烈, 李京燮, 宋炳基. 癥瘕患者에 對한 臨床的 考察. 大韓韓方婦人科學會誌 4(1):23-27, 1991
26 李克光, 金匱要略譯釋. 上海, 上海科學技術出版社. pp 641, 1993
27 West, C.P., Lumsden, M.A., Lawson, S., Williamson, J., Baird, D.T. Shirinkage of uterine fibroids during therapy with goserelin(Zoradex) : a lutenizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot. Fertil. Steril. 48:45-51, 1987
28 Gambone, J.C., Reiter, R.C., Lench, J.B., Moore, J.G. The impact of a quality assurance process on the frequency and confirmation rate of hysterectomy. Am. J. Obstet. Gynecol. 63:545-550, 1990
29 Miller, N.F., Ludovici, P.P. Origin and development of uterine fibroids. Am. J. Obstet. Gynecol. 70:720, 1985
30 宋炳基. 韓方婦人科學. 서울, 杏林出版. pp 251, 254-256, 1992
31 Lee, B.S., Marolin, S.B., Nowa, R.A. Pirfenidone: A novel pharmacological agent that inhibit leiomyoma cell proliferation and collagen production. J. Clinic. Endocrinol. Metab. 83:219-223, 1998   DOI   ScienceOn
32 백원민. 자궁근종의 임상적 고찰. 대한산부인과학회지 26: 1047-1054, 1983
33 萬全. 萬氏婦人科. 湖北, 湖北人民出版社. pp 10, 1983
34 Stewart, E.A., Faur, A. The future of fibroid therapy. Contemp. Obstet. Gynecol. 45:26-35, 2000
35 巢元方 著. 丁光迪 主編. 諸病源候論校註(下). 北京, 人民衛生出版社. pp 1107-1110, 1992.
36 한의부인과학 편찬위원회. 韓醫婦人科學. 서울, 도서출판 정담. pp 303-313, 2002
37 許浚. 原本 東醫寶鑑. 서울, 南山堂. pp 490, 1991
38 대한산부인과학회. 부인과학(3판). 서울, 도서출판칼빈서적. pp 473-488, 1991
39 吳謙 等編. 醫宗金鑑下冊. 北京, 人民衛生出版社. p 38, 1982
40 鄭奉天. 子宮筋種의 治驗. 大田大學校論文集. 1(1):15-33, 1992
41 李尙仁, 金東傑, 李暎鍾, 盧昇鉉, 朱榮丞. 方劑學. 서울, 永林社. pp 245-246, 1990
42 宋炳基. 漢方婦人科學. 서울, 杏林出版社. pp 249-256, 1980
43 王曉萍. 婦産科病症治精要. 北京, 科學技述文獻出版社. pp 208-236, 1999
44 王肯堂. 六科準繩. 서울, 大星文化社. pp 252-268, 1992
45 張機. 金匱要略自學輔導. 서울, 中醫古籍出版社. pp 172, 173, 1988
46 문구, 조성각. 積聚處方에 對한 文獻的 考察. 大韓韓方腫瘍學會誌 1(2):315-329, 1996
47 Sumitani, H., Shozu, M., Segawa, T., Murakami, K., Yang, H.J., Shimada, K., Inoue, M. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism. Endocrinology 141:3852-3861, 2000   DOI   ScienceOn
48 Niu, H., Simari, R.D., Zimmerman, E.M., et al. Nonviral vector-mediated thymidine kinase gene transfer and ganciclover treatment in leiomyoma cells. Obstet. Gynecol. 91:735-740, 1998   DOI   ScienceOn
49 aek, W., Kim, D., Jung, N., Cha, S., Bae, I., Cho, C., et al. Increased expression of cyclin G1 in leiomyoma compared with normal myometrium. Am. J. Obstet. Gynecol. 188: 634-639, 2003   DOI   ScienceOn
50 王氷 註. 黃帝內經. 서울, 高文社. pp 75, 80, 112, 123, 147, 172, 281, 296, 353, 1971
51 Nowak, R.A. Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors. Environ. Health Perspect. 108 Suppl 5:849-853, 2000   DOI   ScienceOn
52 裵恩敬, 李京燮, 宋炳基. 子宮筋腫의 韓醫學的 接近. 大韓韓方婦人科學會誌 7(1):79-86, 1994